Closed-Loop Insulin Therapy Improves Children's Blood Sugar.
Closed-loop Insulin Therapy Improves Glycemic Control in Children with Type One Diabetes.
Type One Diabetes is a common endocrine problem in children and its rate is growing. The risk of long-term problems such as cardiovascular and microvascular could be reduced by improving glycemic control. In spite of the accessibility of therapeutic options such as self-monitoring of blood glucose, rapid-acting insulin analogues, planned patient education, and insulin pump therapy, glycemic control in the majority of patients with type one diabetes continues to be suboptimal. The major obstacle in strengthening the control is the increased risk of hypoglycemia. Nocturnal hypoglycemia was a common occurrence in 8.5% of nights and often had a prolonged duration greater than or equal to two on 23% of nights (Dauber & Corcia, 2012). This paper is about using research to evaluate the improvement of nocturnal glycemic control as well as meal glycemic response using closed-loop therapy in children under age seven. The paper will include clinical findings that are current, thorough, relevant to diabetes, and the nursing practice. Closed- loop therapy is an involuntary method in which an operation or a mechanism is controlled by the response of a meal. In type one diabetes, closed-loop systems constantly control insulin delivery according to an existing glucose level. According to the research, the closed-loop with meal announcement was used where the glucose controller is provided with the information about the time and size of the meal (Dauber & Corcia, 2012).
In the mechanical insulin delivery system by means of a glucose-responsive, the closed- loop system has often been cited as the “Holy Grail” of type one diabetes management. Reflecting the technological advances in interstitial glucose measurements and wider use of continuous glucose monitoring, recent studies in closed-loop glucose control have focused on the subcutaneous route for glucose measurement and the
Type One Diabetes is a common endocrine problem in children and its rate is growing. The risk of long-term problems such as cardiovascular and microvascular could be reduced by improving glycemic control. In spite of the accessibility of therapeutic options such as self-monitoring of blood glucose, rapid-acting insulin analogues, planned patient education, and insulin pump therapy, glycemic control in the majority of patients with type one diabetes continues to be suboptimal. The major obstacle in strengthening the control is the increased risk of hypoglycemia. Nocturnal hypoglycemia was a common occurrence in 8.5% of nights and often had a prolonged duration greater than or equal to two on 23% of nights (Dauber & Corcia, 2012). This paper is about using research to evaluate the improvement of nocturnal glycemic control as well as meal glycemic response using closed-loop therapy in children under age seven. The paper will include clinical findings that are current, thorough, relevant to diabetes, and the nursing practice. Closed- loop therapy is an involuntary method in which an operation or a mechanism is controlled by the response of a meal. In type one diabetes, closed-loop systems constantly control insulin delivery according to an existing glucose level. According to the research, the closed-loop with meal announcement was used where the glucose controller is provided with the information about the time and size of the meal (Dauber & Corcia, 2012).
In the mechanical insulin delivery system by means of a glucose-responsive, the closed- loop system has often been cited as the “Holy Grail” of type one diabetes management. Reflecting the technological advances in interstitial glucose measurements and wider use of continuous glucose monitoring, recent studies in closed-loop glucose control have focused on the subcutaneous route for glucose measurement and the
References: . Dauber, A., Corcia, L, (2012, October 1). Closed -loop insulin therapy improves glycemic control in children aged